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ABSTRACT
Factors associated with the achievement of abstinence were examined among
343 opiate addicted older adults (average age 56.5 years old) who were
participants in longitudinal studies conducted by Anglin and colleagues.
Participants’ responses to survey questions on factors such as physical health
status, mental health status, gender, social support, and Alcoholics Anonymous
(AA) involvement were investigated to examine their association with
achievement of short-term abstinence (defined as no illicit substance use within
the past 30 days) and long-term abstinence (defined as no illicit substance use
within the past year). Logistic regression analysis was conducted to determine
the nature and strength of the relationship of these predictor variables and
abstinence. It was predicted that individuals with less reported physical health
issues will be more likely to be abstinent, while individuals with more reported
mental health issues will be less likely to be abstinent. Further, men would be
less likely to be abstinent than women; while individuals with higher reported AA
involvement will more likely to be abstinent. It was found that the current sample,
when compared to same age and gendered peers, was overall sicker that
national outpatient psychiatric norms. The results also found that higher mental
health status was able to significantly predict both higher short and long-term
abstinence. It was also found that higher AA involvement was associated with
higher abstinence in both the short and long term.
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CHAPTER I: Introduction
The Baby Boomer generation (those born from years 1946-1964; United
States Census Bureau, 2006) is a unique and well-studied generation (Beullens
& Aertgeerts, 2004; Lofwall, Brooner, Bigelow, Kindbom, & Strain, 2005; Merrick,
et al., 2008; Patterson & Jeste, 1999). According to U.S. Census data,
individuals aged 50 and older was estimated at 83.2 million from 2002-06; this is
expected to increase to 115.6 million by 2020. As Baby Boomers age and move
into older adulthood, the increase in the number of older adults will have a
considerable impact on the existing health care system and community
resources, due to age-related health problems.
The Baby Boomer generation was not only exposed to social change, it
was also characterized by a break from traditional norms, including increased
drug use than their older generational counterparts (Colliver, Compton, Gfroerer,
& Condon, 2006). Several studies support the continuation of substance abuse
issues in older adulthood (Colliver, et al., 2006; Levy & Anderson, 2005; Duncan,
Nicholson, White, Bradley, & Bonaguro, 2010; Gfroerer, Penne, Pemberton, &
Folson, 2003; Han, Gfroerer, Colliver, Penne, 2009; Hser, Longshore, & Anglin,
2007). More specifically, in a 33-year follow up study of opiate dependent
individuals, Hser, Hoffman, and Grella (2001) found that over time, Baby
Boomers had an increase in methadone maintenance treatment participation.
The same study also found that continued substance use by older adults did
appear to influence several health and quality of life factors: the individuals who
were currently using heroin had higher rates of disability, mental health issues,
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daily alcohol intake, cigarette smoking, other illicit drug use, criminal involvement,
and lower rates of employment (Hser, et al., 2001). Further, one study of 13,749
substance use treatment facilities across the United States found that only 17.7%
(2374) of these facilities reported having specialized treatment for older adults
(Schultz, Arndt, & Liesveld, 2003). There is increasing evidence suggesting that
addiction is a cyclical and chronic condition, where each relapse is often
characterized by multi-systemic resource utilization and costly treatment
episodes (Dennis, Scott, Funk, & Foss, 2005). Previous addiction treatment
models operating from an acute care perspective were ill-equipped to address
substance use disorders (SUDs) as a chronic condition (Grella & Hser, 1997)
and a succession of acute care treatment episodes is not the same as continuing
care for a chronic condition (Gossop, 2002).
Thus, as Baby Boomers age, it is projected that the number of SUDs for
older adults will also increase. More concisely, substance use disorders were
estimated at 2.8 million from 2002-06 among older adults (ages 50 and older).
This figure is expected to double to 5.7 million in 2020 (Han, et. al., 2009). This
sheer increase will present unique challenges not only in treating these
individuals, but also addressing the unique issues of an aging population.
Following the shift to evidence-based practices (Broekaert, Autrique,
Vanderplasschen, & Colpaert, 2010), SUD treatment is shifting to a chronic care
model, providing tools to facilitate patients improving life in multiple areas (Laudet
& White, 2010). In order to be utilized effectively, continuing care treatment has
to be patient-driven, meeting quality of life issues to achieve recovery from SUDs
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(Laudet & White, 2010) and taking a more holistic approach to treatment and
recovery (De Maeyer, et. al., 2011). From this standpoint, abstinence from
substance use is one component of a multifaceted recovery. Thus, investigation
and identification of factors associated with abstinence among Baby Boomers will
help to target treatment interventions and program resources, working to alleviate
the multi-systemic strain on community, social, and fiscal resources.
A common stereotype suggests that older adults do not use substances,
especially not to a level that could cause difficulties or impairment (Blow, 1998).
It was often thought that older adults who may have had substance abuse issues
earlier in life simply aged out of the problem (Blow, 1998). However, operating
with this bias results in information gaps in assessment, diagnosing, and treating
SUDs in older adults. For example, Molinari, Kier, & Kunik, (2002) identify a
number of challenges mental health professionals have with the identification and
treatment of SUDs in older adults, as follows: (a) psychological and physical
health issues resulting from SUDs and the effects of aging may mistakenly be
attributed to falls, memory loss, and isolating behaviors; (b) training and
experience among mental health clinicians is limited, evidenced by a survey of
mental health professionals, which found that 32% had no formal training in
geriatrics, while 74% of the professionals stated that they wanted training; and (c)
clinicians spent over half their time working with older adults.
However, as several studies suggest, older adults do continue to use
drugs (Hser, Hoffman, Grella, & Anglin, 2001; Hser, Anglin, & Powers, 1993),
drink alcohol (Merrick, et al., 2008), use heroin (Hser, 2007; Hser, Longshore, et
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al., 2007), and abuse over-the-counter and prescription medications (Stevenson
& Masters, 2005), due to the chronic nature of SUDs (Boeri, Sterk, & Elifson,
2006; Levy & Anderson, 2005). In a national study of 862 homeless and lowerincome adults over age 50, it was found that 24% had a current alcohol problem
and 8% had a current drug problem (Dietz, 2009). The actual prevalence may be
higher due to self-reporting issues (e.g. minimizing problems or unwillingness to
self-disclose problems), and difficulties with diagnosis of SUD’s in older adults. It
is more difficult to diagnose older adults with substance abuse issues due to an
increased susceptibility to neurotoxic effects of substance abuse (Crews &
Boettiger, 2009; Moore, Endo & Carter, 2003). In addition, chronic drug abuse
may also exacerbate age related changes in the brain (Dowling, Weiss, &
Condon, 2008).
Heroin use among an older adult population is an area with growing
research, but continues to lack in-depth detail as compared to studies with other
substances (Higgs & Maher, 2010). There are some preliminary findings that
support continued opiate use into older adulthood. In a statistical analysis of 17
surveys conducted from 1982- 2000, Armstrong (2007) looked at a total of
452,567 participants who responded to the National Household Survey on Drug
Abuse. He found that among Caucasian participants born in 1945 and later, the
prevalence of intravenous drug use increased markedly when compared to other
birth cohorts, concluding that those born in the late 1940s and early 1960s have
a considerably higher likelihood of having ever injected drugs (Armstrong, 2007).
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Assessment tools and biases may often fail to accurately account for the
influence of aging on substance abuse presentation (Beullens & Aertgeerts,
2004). For example, DSM-IV-TR criterion for tolerance is inapplicable to older
adults because older adults often have higher substance sensitivity, such as a
higher blood alcohol level with lower consumed amounts of alcohol (Menninger,
2002). Similarly, older adults may not spend a good amount of time doing things
related to substance use, have fewer regular activities and responsibilities
interrupted, and often have fewer major role obligations (Menninger, 2002; Moos,
Brennan, Schutte, & Moos, 2004). Modifications to substance use diagnostic
criteria for older adults have been recommended for over 10 years (Patterson &
Jeste, 1999), and with the increase in an older adult population, it seems fitting to
develop an understanding of this population and factors related to abstinence.
Updated assessment measures can help clinicians more accurately assess for
SUD’s (Sorocco & Ferrell, 2006). As assessment measures improve and biases
are slowly lessened, it seems likely that there may be an increase in older adults
who are diagnosed and enter into treatment for substance abuse issues.
Further complicating accurate assessment is that older adults may be less
likely to disclose their substance use (Rockett, Putnam, Jia, & Smith, 2006) and
may (incorrectly) perceive that they have control over their substance use (Boeri,
et al., 2006). In a study of individuals seeking treatment in the emergency room,
it was found that individuals 65 years and older were twice as likely to refuse
alcohol screening as other age groups. This study also found that females who
were 65 years and older were more likely to not disclose illicit use, with those
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using opioids, benzodiazepines and stimulants/amphetamines being the
substances that were most likely to not be disclosed to treatment providers.
Research on substance use among older adults has been limited with individuals
with drug use disorders, which may be related to a high mortality rate among
individuals with drug use disorders. Neumark, Van Etten, & Anthony (2000)
found that individuals with a drug use disorder die an average of 22.5 years
earlier than individuals without drug use disorders. This leaves a smaller sample
to study and from whom to develop effective treatments.
To effectively utilize resources for treatment of SUDs from a continuing
care perspective, it is helpful to understand what impacts substance use among
older adults and what contributes to abstinence. Identifying and developing an
understanding of these issues will serve to inform and develop more specific and
effective treatments, minimizing the breadth of the impact of this aging
generation. Several factors that influence recovery in substance use disorders
have been identified in older adults, and they include physical health issues,
mental health issues, gender, social support, and 12-step/Alcoholics Anonymous
group involvement (Beynon, 2009; Colliver et al, 2006; Gossop, Stewart, &
Masden, 2007; Lofwall et al., 2005; Tonigan, Miller & Connors, 2000; Williamson,
Darke, Ross, & Teessib, 2009). These factors are explored in more detail below.
Physical Health Issues
The aging process impacts physical health, causing deterioration in
physical functioning and change in brain structures over time. Chronic drug use
may exacerbate these changes, creating a discrete set of problems unique to this
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group that needs further examination (Beynon, 2009). In one study of individuals
with SUDs, the older patients reported the most severe physical health issues in
comparison to their younger counterparts; using heroin or other opiates were
found to be associated with these more severe physical health issues
(Williamson, et al., 2009). In a national study of homeless and low-income
individuals over age 50, Deitz (2009) found that having a current health problem
doubled the odds of having a current alcohol problem.
In a comparison of younger and older adults receiving opioid-substitution
treatment at Johns Hopkins Medical Center (Lofwall et al., 2005), it was found
that the older adults with opioid use disorders had higher rates of cardiovascular,
gastrointestinal and bone/joint problem, as compared to the younger adults in
this sample, with hypertension being the most common. Further, the older adult
group was taking more prescription meds daily, cited at 43.9% of the sample.
However, the mean age of the older adults in this study was 53.9 years old, and
this could be a very conservative estimate of the health issues that older adults
face. Additionally, Colliver and colleagues (2006) found in the National
Household Surveys on Drug Abuse (presently known as the National Survey on
Drug Use and Health (NSDUH)) study that older adults enrolled in substance
abuse treatment are more likely to present with comorbid physical problems. A 5
year follow-up study from the Drug Abuse Treatment Outcome Studies (DATOS)
identified that over one-third (34.7%) of the 432 individuals enrolled in outpatient
methadone treatment continued to report physical health limitations, a significant
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difference when compared to 1-year follow-up data (Hubbard, Craddock, &
Anderson, 2003).
In a study of 108 older male narcotics addicts in California, Hser and
colleagues (2004) found that the participants reported worse physical functioning,
greater role limitation due to physical or health issues, and worse general health
perception overall than the general population of the same age cohort. This
suggests that the physical health issues continue to persist and be a factor in
functioning for narcotics addicts.
Physical health issues often open up a gateway for substance use
disorders, with individuals obtaining pain medication via medical providers. In a
national study of adults aged 18-80 years old who were prescribed opiate
medication, 55% of the national sample never had used an illicit drug; while 4.5%
(10 million people) have used prescription opioids in the past year for nonmedical use. Of these 10 million people who used prescription opioids in the
past year for non-medical use, 13% met criteria for opioid abuse or dependence
(Becker, Sullivan, Tetrault, Desai, & Fiellin, 2007). This is a figure that is
projected to increase with the increase of the older adult population.
Complicating these numbers is the finding that prescription and over-the-counter
medication abuse is climbing (Blazer & Wu, 2009; Lessenger & Feinberg, 2008;
McCabe, Cranford, & West, 2008). Specifically, past year prevalence of the
diagnosis of prescribed sedative abuse/dependence and opioid
abuse/dependence increased from 1991-92 to 2001-02 and the majority were not
enrolled in treatment in the last year (McCabe et al., 2008). In addition, pain
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prescription medication diversion was found to be the main source of these
substances, according to the work done by Lessenger and Feinberg (2008).
That is, the main source of abused opioids is from medical prescribers who need
to be better informed to address these issues with their patients.
Physicians have indicated discomfort in addressing substance misuse with
their patients, endorsing that discussions about prescription drug abuse were
more difficult than discussions regarding alcohol abuse or depression (Boddiger,
2008; McCabe, et al., 2008). Shafer (2004) also discussed in a review of the
literature that the older individuals are higher utilizers of medical care than
younger individuals, in part due to age-related health issues. As the medical
contacts may be the only treatment contact these older individuals have, it is
imperative physicians are able to screen for substance use disorders.
Furthermore, Shafer argues that a “double denial” (p. 346) occurs when clinicians
not trained in substance use disorders combine with caregiver's lack of training
and knowledge regarding healthy behaviors of older adults, creating a treatment
gap for older adults.
As clinicians often use screening questionnaires to diagnose treatment
issues, a concern arises when SUD questionnaires may not accurately assess
these issues in older adults. Assessment instruments, such as questionnaires,
are often based on DSM-IV-TR criteria, which often are not accurate in
encompassing the symptoms of SUDs in older adults (Menninger, 2002).

This

is a concerning finding and supports the notion that treatment providers need to
have a better understanding of idiosyncratic characteristics of substance abuse
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among older adults and more accurate assessment measures in order to screen
for these issues.
As physical health issues increase, utilization of treatment providers,
namely emergency rooms, is also likely to increase for older adults, placing a
strain on treatment resources (Hampton, 2009). Baby Boomers have less
hesitation than previous generations about going to the ER and admission rates
are steady, so the ER visits appear to be for serious medical issues (Berger,
2008). Disturbingly, ER visits for patients 65-74 years old increased by one third
from 1993-2003; by 2013, ER visits could double from 6.4 million to 11.7 million
visits by patients 65-74 years old (Hampton, 2009). Understanding effective
treatment interventions, as well as addressing substance use disorders from a
chronic care perspective, may serve to alleviate this strain at the acute care level.
Additionally, physical health issues can be a major source of stress,
impacting social and occupational roles, and psychological well-being. Folkman,
Bernstein, and Lazarus (1987) found that the higher the perceived stress, the
higher the likelihood of an older adult misusing substances. They also found that
48% of older adults, misused drugs and that this misuse was associated with
perceived stress emotions. Specifically, the older adults who identified more
negative threat emotions (such as worry and fear) with their stressful encounters
were more likely to misuse substances than those who did not misuse
substances. Therefore, not only do older adults present with more physical
health issues, they also present with higher levels of stress related to physical
health issues. Addressing physical health issues and understanding the impact
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that they have on achievement of abstinence and recovery can provide more
well-rounded and efficacious treatment for older adults.
Mental Health Issues
Co-morbid mental health and substance use disorders, or dual diagnosis,
is another factor that is associated with difficulty in maintaining abstinence. Often
a substance use disorder develops from an attempt to self-medicate an
underlying mental health problem, creating two illnesses that are often
intertwined and difficult to manage (Moos, Mertens, & Brennan, 1993). Among
substance users over age 55 who were admitted to inpatient treatment, in a
study done by Moos, Mertens, and Brennan (1993), 20% were in dual diagnosis
units. Further, the adults over age 55 were more likely to have organic brain
damage and paranoid psychosis, and to require longer episodes of psychiatric
care and medical detox, as compared with the younger adults in this sample.
Prevalence of co-morbid mental health issues among individuals with
substance use disorders is high. One study of primarily opioid users found
comorbidity of substance use disorders and another mental health issue at 67%
(Thomasius, Sack, & Petersen, 2010). In a national study of over 20,000
participants, (Reiger, et al., 1990) 37% of the individuals with alcohol use
disorders and 53% with drug use disorders were found to have co-occurring Axis
I psychiatric issues. Reiger and colleagues (1990) also found that individuals
diagnosed with schizophrenia were three times as likely to have problems with
alcohol and six times as likely to have problems with drugs than individuals
without a schizophrenia diagnosis. Grant and colleagues (2004) found using
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data from the NESARC (National Epidemiologic Survey on Alcohol and Related
Conditions), a household probability sample of 43,093 individuals, that individuals
diagnosed with alcohol use disorder, almost 41% had at least one co-occurring
independent mood disorder. In the same study, the figures for co-morbidity were
even higher for those with drug use disorders: among individuals seeking
treatment for a drug use disorder, 60% had at least 1 independent mood
disorder. Other studies have found the range of dually diagnosed to range from
20% (Grant, et al., 2004) to 47% (Brooner, King, Kidorf, Schmidt, & Bigelow,
1997) these estimates are dependent upon how individuals were sampled and
the types of diagnostic instruments used.
Sub-diagnostic psychological distress is also highly prevalent among
individuals with substance use disorders, as discussed in a study conducted by
Ross and colleagues (2005). Looking at 825 current heroin users in Australia,
Ross and colleagues identified that 49% reported some level of psychological
distress that was significantly higher when compared with population norms. As
co-occurring mental health issues present often in individuals with substance use
disorders, consideration of the impact of mental health issues among those
individuals being treated for substance use disorders appears imperative to
achievement of abstinence and sustained recovery.
Mental health issues and substance use have been shown to be
correlated, although the relationship with abstinence is not well understood.
Some studies suggest that there is no relationship among psychiatric comorbidity and relapse with substance use disorders (Di Sclafani, Finn & Fien,
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2007). However, Xie, Drake, Mchugo, Xie, and Mohandas (2010) investigated
the achievement of abstinence among 223 individuals dually diagnosed with
mental health issues and alcohol use disorders over a 10-year period; finding
that individuals with decreased psychiatric symptoms (presumably to treatment
interventions to manage symptoms) were more likely to maintain abstinence.
Hser, Huang, Chou, & Anglin (2007) investigated 471 incarcerated males in a 33year follow-up study and found that individuals who quit using heroin earlier in life
also had a significantly lower level of psychological problems than individuals
who continued to use later in life. Maremmani and colleagues (2008) found
similar results in a 6-year longitudinal study of 129 individuals on methadone
maintenance, finding that concurrent psychiatric disorders were the strongest
negative predictor of relapse, regardless of other clinical and socioeconomic
variables. Skinner, Haggerty, Fleming, Catalano, and Gainey (2011) conducted
a 12-year follow-up study with 144 opiate-dependent individuals, and found that
mental health issues (namely depression) can be a significant factor in continued
drug use. Further evidence to support that mental health disorders can influence
treatment outcomes is Freeman, Maxwell, and Davey’s (2011) study of
approximately 345,000 individuals who were mandated to DUI treatment from
2005-2008. Freeman and colleagues found that individuals with a co-occurring
Bipolar Disorder diagnosis were less likely to complete treatment than peers
without a Bipolar Disorder diagnosis.
In Lofwall and colleagues (2005) comparison of older (ages 50-66) and
younger (ages 25-36) adults in opioid maintenance programs, mood disorders
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(Major Depressive Disorder, Bipolar Disorder, and Dysthymic Disorder) were the
most common among the older individuals. The high prevalence of mood
disorders among substance using older adults could be explained by schematic
patterns that have developed over time, in addition to grief, loss of
companionship, loss of social roles, and lowered standard of living. In a study of
141 older adults (ages 65-74), Folkman, et al. (1987) illustrated that older
individuals who misuse drugs were more likely to have negative schemas related
to stress and problem solving, than their non-using peers, which impact their
mental health, specifically in presentations of depression and anxiety.
Trauma and exposure to multiple traumas is a topic that is beyond the
scope of this paper. However, it is important to note the prevalence of trauma
among individuals with substance use disorders. In a study of 587 individuals,
Khoury, Tang, Bradley, Cubella, and Ressler (2010) found that high rates of
lifetime dependence on various substances was strongly correlated with current
PTSD symptoms as well as childhood physical, sexual, and emotional abuse.
Identifying and treating trauma and PTSD among individuals with substance use
disorders may help in the process of recovery and the achievement of
abstinence.
Personality disorders are also, by definition, long-standing, and Axis II
issues can further complicate achievement and maintenance of abstinence. In a
study of 187 individuals with alcohol use disorders, it was found that having a cooccurring personality disorder was significantly associated with a shorter latency
to relapse among outpatient individuals, especially within the first 3 months of
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treatment (Verheul, van den Brink, & Hartgers, 1998). As this study was focused
on individuals with alcohol use disorders, more information is needed on relapse
among dually diagnosed opiate using individuals.
Individuals presenting with dual diagnosis issues may require extra help in
maintaining sobriety, as they have two chronic mental health issues to manage.
Due to substance use issues, dually diagnosed individuals are more susceptible
to destabilization of mental health and decreased adherence to treatment
(Green, Drake, Brunette, & Noorday, 2007). This leaves treatment providers
often struggling with the individual to manage the co-occurring disorders, and
more information on the relationship with mental health issues and relapse would
begin to support a foundation for the development of treatment interventions.
Further challenging treatment and the achievement of abstinence is the stigma of
mental health issues and substance use disorders. The stigma has been found
to have lasting effects, including contribution to continued depressive symptoms,
even when the dually-diagnosed individuals are responsive to treatment
interventions (Link, Struening, Rahav, Phelan, & Nuttbrock, 1997).
As Baby Boomers grow older and the number of older adults continues to
increase, it seems likely that inpatient units will not be equipped to deal with an
increasing amount of older individuals with dual diagnosis issues (Koenig,
George, & Schneider, 1994). Inpatient treatment is used to manage medical
detoxification from many substances, including opioids, and inpatient stabilization
may be necessary for those who require stabilization of acute co-occurring
medical or psychiatric conditions. However, it is projected that the older adults
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with physical and psychological issues are more likely to be treated on an
outpatient basis (Koenig, et al., 1994), as the strains on inpatient care will be
significant. Also complicating this issue will be access to service delivery and the
willingness of the younger generation of adult children of Baby Boomers to
address dual diagnosis treatment needs, a virtually non-investigated topic
(Koenig, et al., 1994).
Gender
Unique characteristics that stem from gender differences in substance
abuse are well studied. Often the obstacles that women face are significantly
different from the obstacles that men experience (Grella & Joshi, 1999). For
example, in a study of 211 patients of primary care clinics age 55 to 91 years,
men were found to report lifetime abstinence and score higher on a measure of
problem substance use than did women (Satre & Arean, 2005). Understanding
gender influences and aging on substance abuse will help to elucidate further
understanding of this population and clarify more effective treatment targets.
Many substance use disorder studies looking at gender have focused on
alcohol use, citing that men are more likely to drink than women (Chan, von
Mühlen, Kritz-Silverstein, & Barrett-Connor, 2009; Crome & Crome, 2005).
However, women are also socialized to avoid public intoxication (Brennan, Moos,
& Kim, 1993); consequently, problems related to substance use may be more
hidden. Ziegler (2008) found that older adult women are more likely to drink
alone and the concept of telescoping is an important concern. The telescoping
effect is where women start using later, but progress to later stages of addiction
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earlier (in a shorter amount of time). Further, Ziegler also found in a study
conducted by the National Center on Addiction and Substance Abuse (CASA) at
Columbia University (1998), that less than 1% of the 2 million women over age
59 actually receive treatment for alcohol abuse and dependence. This same
study further suggests that women tend to use minimization, rationalization and
externalization as part of their presentation when speaking about their alcohol
use, making it challenging for treatment providers to get an accurate assessment
of the clinical picture (Ziegler, 2008). However, telescoping may not be as
applicable to individuals who are using opiates. In a study of 599 individuals
(mean age 33 years old; average age at first use was 20.9 years old) diagnosed
with opiate dependence, the telescoping effect was minimally observed in the
first 4 years of opiate dependence (Hölcher, et al., 2010). Hölscher and
colleagues (2010) explain that opiate dependence often leads to chronification,
which does not lead to significant differences across gender or length of
consumption.
Gender factors may contribute to selection of an individual’s substance of
choice; with females choosing more “socially acceptable” substances, such as
prescription drugs. In a national study of 22,460 adults who used medical care
services, Simoni-Wastila (2000) found that being female increases the odds of
using any abusable prescription drug by 48% and women were more likely to use
narcotics and anxiolytics than their male counterparts. Factors associated with
nonmedical use of prescription drugs include older age, female gender, poor/fair
health status, and daily drinking (Simoni-Wastila, & Strickler, 2004). Further,

18
men were more likely to develop prescription drug abuse, while women were
more likely to develop prescription drug dependence (McCabe, West, Morales,
Cranford, & Boyd, 2007).
Further looking at gender differences in individuals with substance use
disorders across several treatment modalities, Grella and Joshi (1999) found a
wealth of information, including that more women (59.2%) had prior drug
treatment when compared to men (53.9%). Grella and Joshi also found that
when compared to men, women were younger when entering treatment, more
likely to have been married, more likely to be single parents, and more likely to
have exchanged drugs for sex or money. Although men have an earlier age of
first drug use and have tried a greater number of drugs than women, women
reported a shorter interval of time between first regular drug use and first
treatment entry than men (Grella & Joshi, 1999). The authors also looked at
complicating external factors, with men more likely to be involved in criminal
justice system, women more likely than men to have had mental health treatment
and to meet criteria for Generalized Anxiety Disorder or Major Depressive
Disorder. Men also have more family support and encouragement to enter
treatment, while women are less likely to be pressured by spouse to enter
treatment (Grella & Joshi, 1999).
A study by Hser, Joshi, Maglione, Chou, & Anglin (2001) found that
women (majority over age 30 at admission) were more likely to complete
methadone maintenance treatment and outpatient drug free programs than men.
The Project MATCH study found that women diagnosed with alcohol
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dependence have less severe relapse patterns than men diagnosed with alcohol
dependence and the women appeared more willing to seek treatment following a
relapse (Project MATCH, 1997).
Therefore, previous findings suggest that gender accounts for some
variability in treatment utilization and outcomes, especially as a covariate with
other factors, such as mental health issues or social support. A review of the
literature on substance abuse treatment entry, retention and gender by
Greenfield and colleagues (2007) cited the need for further follow-up studies with
older individuals and individuals with co-occurring mental health issues. The
present study will help to elucidate the impact of gender on abstinence,
specifically in relation to other salient treatment factors with an older population,
such as social support.
Social Support and Functioning
Social support is a factor that is often lacking for individuals with
substance use disorders, with females remaining more socially integrated than
males (e.g. women are more likely to be living with their dependent children), as
Grella and Joshi (1999) found; male substance users tend to have greater
involvement in the criminal justice system (Grella & Joshi, 1999). Thus, social
support may be a protective factor that results in less severe or less prevalence
in alcohol-related problems for women. However, women who do have
substance use disorders may be less likely to seek help and more likely to have
stressful relationships with a spouse or family- particularly if their substance use
is embedded within the relationship dynamics (Brennan, et al., 1993).
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Bereavement, social isolation, lack of social support and financial difficulties can
cause social problems and contribute to continued substance misuse (Gossop &
Moos, 2008). Additionally, social stigma around substance use issues has been
identified as a barrier for individuals entering into substance abuse and/or mental
health treatment (Connor & Rosen, 2008), in addition to the stigma of aging and
continuing to experience substance use issues. The socio-emotional career of
the older substance user is marked by loneliness, stress, and fear of
victimization; like many older adults, they prefer to “age in place” (p. 256) by
remaining in a familiar socio-environment where they know the rules and what to
expect (Levy & Anderson, 2005). This sense of isolation may be compounded by
age, as older adults may perceive themselves powerless to adjust to the social
norms and physical demands of the current drug world (Anderson & Levy, 2003).
Older adults who attempt to stop using heroin may have a more difficult
time doing so, as the social networks to support recovery have not been
established in the earlier life course (Hser, 2007). In a study of 24 older adults
on methadone maintenance treatment for opiate dependence, a lack of trust was
identified as the main obstacle to use and expansion of social supports (Smith &
Rosen, 2009). Increasing social supports and working to overcome obstacles to
social support may be helpful in treating an already isolated older adult
population.
With aging also comes the loss of social supports through death of family
and friends, which can be a profound loss for older adults. Multiple losses can be
extremely traumatic for older adults (person, financial, home, etc.) and further
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understanding is needed to assess the strength of the relationship between loss
and substance use disorders. In a review by Shafer (2004), older adults often
are not using substances for recreation, but for a therapeutic effect, such as relief
from grief or pain. Older adults are more likely than younger adults to use/drink
alone when compared to their younger counterparts (Neve, Lemmens, & Drop,
1999). Further, Sorocco and Ferrell (2006) looked at older individuals diagnosed
with alcoholism, and reported that risk factors for addiction include dual diagnosis
issues, isolation, stressful life events, and the environment (e.g. being
homebound, lack of, or difficulty accessing, social or treatment resources in the
community, and more constrictive social hours in assisted living facilities).
In a group comparison study with older adults diagnosed with alcoholism
and those who did not drink, it was found that the alcohol users were more likely
to be depressed, sad, isolated, and have psychiatric issues. The isolation may
be due to not developing connections because of addiction, leading to a vicious
cycle of continued alcohol use (Rivers, Rivers, & Newman, 1991). In a 12-year
longitudinal study of 144 opiate-dependent individuals, Skinner and colleagues
(2011) found that having deviant friends (friends who are using substances) and
changes in marital status were more likely to be associated with continued
substance use, illustrating the influence of social support factors on abstinence
outcomes. In the same study, Skinner and colleagues also found that opiate
users who were in recovery often cited their children or grandchildren as the
important focus of their lives, illustrating how positive social support can be a
factor in maintaining abstinence.

22
Although the literature has investigated social support and functioning as a
variable that is associated with substance use disorders and abstinence, it is
often focused on individuals who substance of choice is alcohol. More research
is needed to address the relationship among social support and functioning and
older individuals with opiate use disorders. Each substance of choice presents a
unique clinical picture and subsequent treatment interventions (for example,
increased discussion around safe needle use would be appropriate for
intravenous heroin users, but less relevant for individuals whose substance of
choice was marijuana). Focusing on how social support and functioning is
associated with abstinence among older individuals with opiate dependence will
help to implement effective treatment interventions.
Fellowships such as Alcoholics Anonymous (AA) and Narcotics
Anonymous (NA) often serve as new support systems for individuals who are
trying to cut down on their substance use. This is often because families isolate
from individuals with substance use disorder issues, or the individual chooses not
to be a part of an unhealthy family or social support system as they work on
recovery.
Alcoholics Anonymous Involvement
Alcoholics Anonymous (AA) originated in 1935 and is a widely known and
well-established support for individuals with substance use disorders
(Humphreys, 2003). Better treatment outcomes have been associated with AA
affiliation, including increased abstinence from alcohol (Moos, & Moos, 2004;
Timko, Moos, Finney, & Moos, 2000) and sustained recovery (Fiorentine, 1999;
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Morgenstern, Labouvie, McCrady, Kahler, & Frey, 1997). Additionally, treatment
costs for those who engaged in AA were shown to be 45% lower than for
individuals who engaged in outpatient treatment, with similar outcome results
after 3 years (Humphreys & Moos, 1996). However, there are unique issues in
AA for individuals with a history of methadone maintenance treatment. As
methadone was considered to be a drug, these individuals were historically
viewed by the AA community as non-abstinent. There is increasing flexibility in
this viewpoint, but there is still variability around the definition of abstinence in the
12-step community (Krentzman, et. al., 2011).
AA is one subset of a greater 12-step support community that includes
Narcotics Anonymous (NA) and Cocaine Anonymous (CA), to name a few
others. As AA was the first 12-step self-help group, it has been the most studied
(Room & Greenfield, 1993). However, studies often group NA and AA together,
as was done by Brown, O’ Grady, Farrell, Flechner, & Nurco (2001), where they
found that individuals who attended AA or NA frequently (at least 3 times a week)
had more serious histories of substance use (for example, starting use at a
younger age, greater number of arrests and/or treatment episodes).
Interestingly, these investigators also found that there was no significant
difference in perceived level of social support and frequency of AA/NA
attendance. The study explains that involvement in AA/NA attract those who can
benefit from the support and continued behavioral reinforcement that 12-step
groups can provide. Considering AA and NA involvement together as 12-step
involvement could help to generalize findings and more accurately discern
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treatment outcomes related to 12-step involvement, as discussed by Room and
Greenfield (1993).
Originally, attendance at AA meetings was the operationalized variable in
treatment studies of AA and treatment outcomes, but more recent studies have
shown that greater involvement in AA (versus just simple attendance) is
associated with more favorable treatment outcomes (Montgomery, Miller &
Tonigan, 1995; Tonigan, Miller & Connors, 2000). An Alcoholics Anonymous
Involvement (AAI) scale was developed by Tonigan, Connors, & Miller (1996) to
assess AA involvement. The AAI scale has been shown to better account for
explanations of variance in abstinence rates than measures of attendance alone,
illustrating that the AAI exhibits greater statistical power (Cloud, Ziegler, &
Blondell, 2004) versus measuring AA attendance alone.
Project MATCH (Matching Alcoholism Treatments to Client Heterogeneity)
(1997) investigated efficacy of treatment options for individuals diagnosed with
alcohol dependence. This study compared 12-step facilitation, cognitivebehavioral skills therapy, and motivational enhancement treatment randomly
assigned 774 individuals coming from inpatient treatment and 952 individuals
who had only received outpatient services (total N = 1,726). The authors found
that individuals without significant mental health issues assigned to the 12-step
treatment achieved significantly greater abstinence rates than those assigned to
the cognitive behavioral treatment option. However, the differences in
achievement of abstinence were not significant for individuals with more severe
mental health issues.
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AA as an effective adjunct in treatment has also been supported in the
literature. For individuals with higher psychiatric severity, abstinence was more
likely to be achieved when psychiatric issues are addressed concordantly (Polcin
& Zemore, 2004), and that individuals with higher psychiatric severity may need
more assistance than others to complete the steps of AA (Polcin & Zemore,
2004). Further, AA involvement after an inpatient treatment stay was more
effective in sustaining abstinence than AA involvement alone (Walsh, et al.,
1991).
Morgenstern et. al. (1997) illustrate that affiliation with AA was significantly
associated with commitment to abstinence and active coping efforts to manage
relapse, in addition to increased self-efficacy. Similarly, Sheeren (1987) found
that AA involvement was not only correlated with lower rates of relapse for
individuals with alcohol dependence, but AA involvement, specifically with
reaching out to other AA members and the use of a sponsor, had the strongest
correlation with maintenance of abstinence.
However, the majority of these studies investigated AA involvement with
individuals who had been diagnosed with alcohol dependence, increasing the
need for empirical support for AA involvement for those who have been
diagnosed with SUD’s with substances other than alcohol. A study by Gossop,
Stewart, et al. (2007) looked at attendance at AA and NA meetings and the
relationship with abstinence among individuals diagnosed with SUD’s other than,
or in addition to, alcohol dependence. The sample of 142 individuals in this study
had been in residential treatment and longitudinal data on abstinence and AA or
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NA attendance was collected. The authors found that abstinence from opiates
was increased throughout the 5 year follow-up period when compared to pretreatment levels. The study also found varying results based on the substance of
choice (Gossop, Stewart, et al., 2007), with some substances, such as stimulants
having only increased abstinence among those attending AA or NA at the 1-year
follow-up only. As this study only looked at 12-step attendance versus
involvement, further investigation into the relationship with AA involvement and
abstinence achievement among individuals with a history of heroin dependence
would increase understanding of what interventions may be efficacious, and costeffective, with individuals with substances of choice other than alcohol.
Present Study
The significant increase in the number of older adults in the next decade
as the Baby Boomer population ages is predicted to place a strain on treatment
providers. As substance use disorders are seen as chronic conditions that
require ongoing (and patient-driven) care, developing an understanding of what
factors are associated with abstinence specifically for older individuals will help to
effectively tailor and allocate treatment resources.
As alcohol use is well studied among older adults (Sorocco & Ferrell,
2006; Menninger, 2002; Liberto, Oslin & Ruskin, 1992), the focus of this study
will be looking at older adults who have a history of heroin dependence. Looking
at the current impact of physical health status, mental health status, gender,
social support, and AA involvement will help to provide an understanding of how
these factors are associated with abstinence in an aging population, and how this
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population compares on these issues when compared with their non-using peers.
These factors will be investigated using follow-up data from a longitudinal study
of Baby Boomer adults. The participants were enrolled in methadone
maintenance treatment for opiate dependence in the late 1970s in Central and
Southern California. It is hypothesized that physical health, mental health,
gender, social support, and AA involvement will be able to significantly predict
the achievement of abstinence in individuals in this sample.
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CHAPTER II: Methodology
Participants
The original cohort of individuals was enrolled in methadone maintenance
treatment programs in six counties in California from 1976-1978 and participants
in one of two separate studies conducted by Anglin & McGlothlin in the 1980’s.
Follow-up data collection with 343 participants was conducted from March 2005
– January 2009, which represents 37.5% of the original study sample. Of the
original sample, 46.8% were identified as deceased, 3.2% were unable to be
interviewed, and 12.5% were unable to be located. For the present study, three
cases were dropped from analysis due to not completing survey data. The final
sample was reduced from 343 participants to 340 participants (Appendix B).
Recruitment Procedures
Individuals were recruited based on their participation in one of the two
previous studies conducted in the 1980s by Anglin and colleagues (Anglin,
Speckart, Booth & Ryan, 1989; McGlothlin & Anglin, 1981). Study participants
were selected via criterion sampling, where all participants had to meet criteria of
being enrolled in methadone maintenance treatment from 1976-1978 in one of
six California counties. Individuals were originally sampled from treatment
program records and invited to participate in the baseline studies, in which a
background and natural history assessment of their drug use, criminal behavior,
and treatment participation was conducted.
Design
The non-experimental study utilized a cross-sectional design using the
data collected in the follow-up study with individuals who were prior participants
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in methadone maintenance treatment. Data analysis was conducted in two
steps. First, independent samples comparison examined whether predictor
variables can distinguish the sample from psychiatric outpatient norms; gender
and age were separated as a co-variate as the measured used is normed by
both age group and by gender. This served to compare the sample with a
psychiatric outpatient sample. Second, logistic regression examined five
predictor variables’ (gender, mental health status, physical health status, social
support and functioning, and AA involvement) ability to predict the outcome
variable of illicit substance abstinence, both in the short- and long-term. As there
were significant differences in average age across gender, age was controlled for
as a co-variate.
Measures
The database includes urinalysis results and data from structured
interviews conducted with participants. Data collection conducted by Grella and
colleagues (Grella & Lovinger, 2011) utilized a structured interview that included
a variety of standardized measures, including the RAND SF-36 item health
survey and the Alcoholics Anonymous/12-step program involvement (AAI Scale).
Self-report measures, such as gender, age, and past history of substance use
were also contained in the interview. In the present study, self-report variables
as well as the SF-36 and the AAI were used. Variable coding is listed in
Appendix C.
Sociodemographics. Relevant self-reported variables for the present
analysis include background characteristics, such as gender, race, and age.
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Gender was based on self-report, and was the first predictor variable used in the
regression analysis. Race was based on participants’ answer to questions that
were based on U.S. Census data questions. Individuals could choose from
White, American Indian/Alaska Native, Asian, Native Hawaiian or Other Pacific
Islander, or Black or African American. Due to the small relative number of
participants in each group, race was grouped as White and Nonwhite.
Additionally, those individuals of Latino and Chicano descent were not separated
out due to the survey following structure per United States Census data
questions. This is addressed in the Limitations section of the study. Regarding
age, the first part of the analysis (comparison with outpatient psychiatric norms),
age was looked at as a categorical variable, as the SF-36 groups age into
categories (45-54; 55-64; 65+). Therefore, mean scores were used for age
groups in comparisons with SF-36 population norms. For the second part of the
analysis, age was looked at as a continuous variable.
SF-36 health and functioning. The second predictor variable used is
physical health status. Using the SF-36 Scale (Ware & Sherbourne, 1992),
physical health status was operationalized using the Physical Health Component
Summary Scale, a 35-item subscale of the SF-36 that measures overall physical
health status, including self-reported functioning such as physical functioning,
bodily pain, and general health. The Physical Health Component Summary
Scale ranges from 0 (poor physical health) to 100 (excellent physical health) and
the validity estimates usually exceed 0.90 (Ware, Kosinski, & Keller, 1994). In
the present study, physical health status was looked at with means for the first
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analysis (comparison to psychiatric outpatient norms). And in the second part of
the analysis, the regression, the study utilized dichotomized scores grouped into
high and low based on the median (Appendix C).
Mental health status is the third predictor variable. Mental health status
was measured using the mental health subscale from the Rand Health Survey
36-item Short Form, abbreviated as the SF-36, (McHorney, Ware & Raczek,
1993; Ware & Sherbourne, 1992). The SF-36 mental health subscale looks at
energy, emotions, social functioning, and mental health. Item scores range from
0 (worst possible health state) to 100 (best possible health state). In the present
study, mental health status was looked at with means for the first analysis
(comparison to psychiatric outpatient norms). And in the second part of the
analysis, the regression, the study utilized dichotomized scores grouped into high
and low based on the median.
Social support and functioning, the fourth predictor variable, was
operationalized using the Social Functioning Subscale from the SF-36 (Ware &
Sherbourne, 1992). This subscale includes measures of social involvement and
social scope. In the present study, social support and functioning was looked at
with means for the first analysis (comparison to psychiatric outpatient norms).
And in the second part of the analysis, the regression, the study utilized
dichotomized scores grouped into high and low based on the median.
AA involvement. AA involvement is the fifth predictor variable used in
the regression analysis. AA involvement is derived from the Alcoholics
Anonymous Involvement (AAI) scale (Tonigan, et al., 1996), which is a 13-item
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self-report inventory that measures both lifetime and recent involvement in AA
programs. The inventory is designed to look at several factors of AA
involvement, including the degree that the individual is “working” the program
(e.g. recent involvement) as well as commitment to AA fellowship. The AAI scale
(Tonigan, et. al., 1996) has good internal item consistency (Cronbach’s α = .85;
N = 1625) and test-retest results indicated the scores were replicable (r =0.76; N
=76), as found by Tonigan and colleagues (1996). For the present study, AA
involvement was only used in the regression analysis, as this scale is not present
on the SF-36. For the AA involvement variable, a composite variable was
created from items from the AA involvement scale. Sample participants were
dichotomously grouped as no involvement (indicating no involvement in working
the steps, attending meetings, etc.) and any involvement (Appendix C).
Abstinence outcomes. Two measures of abstinence were looked at in
the present study, the first being short-term abstinence, defined as no substance
use for the past 30 days, consistent with the research done by Zhang and
colleagues (2011). Long-term abstinence, as defined by several studies (Becker,
et. al., 2001; McCabe, et. al., 2008; McCabe, West, Morales, Cranford, & Boyd,
2007), and DSM-IV-TR criteria for “sustained full remission” (American
Psychiatric Association, [DSM-IV-TR], 2000, p. 196) was defined as no illicit
substance use for at least one year. Abstinence was based on self-report of
substance use and cross-verified with a urinalysis sample collected at the time of
the survey. Individuals testing positive for methadone were considered an illicitdrug free screen, as methadone was considered a therapeutic intervention. All
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other substances, including alcohol, were considered illicit. Further, individuals
who refused to provide a urine specimen were considered illicit; individuals who
were unable were considered non-illicit.
Procedures
Recruitment procedures. The current study was a secondary analysis of
the data collection conducted by Grella and colleagues (Grella & Lovinger, 2011)
from March 2005 – January 2009. Participants for the study were selected
based on their involvement in previous studies conducted in the 1980s by Anglin
and colleagues (Anglin, Speckart, Booth & Ryan, 1989; McGlothlin & Anglin,
1981). Participants and collateral contacts were contact via phone and/or letter
and initially told that the study was concerning a public health issue. Once the
participant was verified as being a part of the original study via their date of birth,
county residence during the original study, and social security number, informed
consent was obtained. Grella and colleagues (Grella & Lovinger, 2011)
conducted this procedure in the follow-up data collection and the present study
will be a secondary analysis of that data collection.
Data collection. Individuals in the initial study were asked to voluntarily
participate in a structured face-to-face interview. Interviewers who were research
staff at UCLA conducted these interviews (most had Bachelor’s level degrees
and several years of experience conducting research interviews). The majority of
these interviews took place at the individual’s home or another location of their
choosing (e.g. a restaurant or another public setting). Each interview took
approximately 2-3 hours to administer, and at the end of the interview,
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participants gave a urine sample (if they were not incarcerated), which measured
the presence of heroin, methadone, cocaine/crack, THC, phencyclidine,
barbiturates, benzodiazepines, amphetamines, and methamphetamines. As
individuals could refuse to give a specimen for urinalysis, only those participants
who consented to give a sample will be included in the present study.
Participants received $100 for completion of the follow-up interview. UCLA IRB
approved all procedures and all participants gave informed consent and were
debriefed and referred as necessary. A federal Certificate of Confidentiality was
obtained to protect the data. Data sharing and IRB exemption approval were
sought for the study through Pepperdine’s IRB and approved on March 22, 2011.
All data analyzed in this study was deidentified.
Data Analysis
Descriptive analysis. Descriptive statistics have been collected on the
population via UCLA researchers/statisticians as part of the original study.
However, as part of the current study, descriptive analysis was run again for
mean and standard deviation for age, breakdown of race, gender, participation
rate from previous study. This serves to contextualize the sample. A basic
correlational analysis was conducted on both the predictor and outcome
variables to determine co-variation among variables and possible multicollinearity
among variables, which could have resulted in possible suppression across
measures.
Comparison to SF-36 norms. For the current study, a two-part analysis
was conducted. In the first analysis, three predictor variables (physical health,
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mental health, and social functioning) were examined with an independent
samples t-test to see how well these variables help distinguish between the
sample population and population norms for psychiatric outpatient individuals.
Additionally, the psychometric properties (e.g. reliability coefficients, distributions)
of the predictor variables in the study sample were examined to assess the
reliability of the scales in this study.
Factors related to abstinence. The second part of the analysis utilized
logistic regression to examine how well five independent variables (gender,
physical health status, mental health status, social support and AA involvement)
predict the outcome variable of abstinence (both short and long-term). As there
were significant differences in average age across gender, age was controlled for
as a co-variate. Odds ratios and 95% confidence intervals are reported for
independent variables entered into the logistic regression models.
Research Hypothesis
The primary research questions and associated hypotheses are
delineated as follows.
Question 1. How well do predictor variables distinguish the current sample
from a psychiatric outpatient normative sample, using age- and gender-specific
norms?
Hypothesis 1a. Reported physical health will not significantly distinguish
between participants and psychiatric outpatient population norms.
Hypothesis 1b. Mental health indicators will not significantly distinguish
between participants and psychiatric outpatient population norms.

36
Hypothesis 1c. Reported social functioning will not significantly distinguish
between participants and psychiatric outpatient population norms.
Question 2. When age is controlled for, how well do independent variables
(gender, physical health, mental health, social support, and AA involvement)
predict the outcome of short-term and long-term abstinence?
Hypothesis 2a. Being a male will have a significant (at the p > 0.5 level),
negative correlation with abstinence. Subsequently, being a female will have a
significant (at the p > 0.5 level), positive correlation with both short-term and
long-term abstinence.
Hypothesis 2b. Physical health status will have a significant (at the p > 0.5
level), correlation with both short-term and long-term abstinence, in that better
physical health will be associated with higher odds of abstinence outcomes,
controlling for other variables.
Hypothesis 2c. Mental health status will have a significant (at the p > 0.5
level), correlation with both short-term and long-term abstinence, in that better
mental health status will be associated with higher odds of abstinence outcomes,
controlling for other variables.
Hypothesis 2d. Social functioning will have a significant (at the p > 0.5
level), positive correlation with both short-term and long-term abstinence,
controlling for other variables.
Hypothesis 2e. Involvement in Alcoholics Anonymous will have a
significant (at the p > 0.5 level), positive correlation with both short-term and
long-term abstinence, controlling for other variables.
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CHAPTER III: Results
Sociodemographics
Table 1 provides descriptive information for the total sample of 340
participants. This sample represents a 37.2% of the original sample of
participants from previous studies conducted in the 1980s by Anglin and
colleagues (Anglin, et al., 1989; McGlothlin & Anglin, 1981). Mean age for the
340 participants at the time of the survey was 57.3 years (standard deviation of
4.7 years) with a minimum age of 47.7 years and a maximum age of 75.9 years.
The mean age for females was 55.4 years (standard deviation 3.7 years) and the
mean age for males was 58.8 years (standard deviation 4.9 years), and there
was a significant difference at the p >.01 level between age across gender as
indicated by a one-way ANOVA [F (1, 338) = 50.190, p = 0.000].
Of the 340 participants, 191 identified as male (56.2%) and 149 identified
as female (43.8%). The majority (93.8%) of the sample identified as White, at
319 participants, and 6.2% of the sample identified as American Indian/Alaska
Native, Asian, Native Hawaiian or Other Pacific Islander, or Black or African
American, which was grouped into the Non-White category. This grouping will be
addressed in the discussion as limitations of the study.
Abstinence Rates
Table 2 provides breakdowns for abstinence by gender. Among the total
sample, a majority (56.8%) had used illicit substances in the last 30 days, and
43.2% of the total sample remained abstinent in the last 30 days. Trends were
similar for long-term abstinence. A majority (63.2%) had used illicit substances in
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the last year, whereas a little over one-third of the total sample (36.8%) achieved
abstinence in the last year.
Among men, 44.5% achieved short-term abstinence; 55.5% used within
the last 30 days. In the longer term, 37.7% of men were able to achieve longterm abstinence; 62.3% used within the last year. Among women, 41.6%
achieved short-term abstinence; 58.4% used within the last 30 days. In the
longer term, 35.6% of women were able to achieve long-term abstinence; 64.4%
used within the last year. Using a one-way ANOVA, there was no significant
difference determined in either short-term [F (1, 338) = 0.162, p = 0.688] or longterm [F (1, 338) = 0.284, p = 0.595] abstinence rates across gender.
A basic correlational analysis was conducted on both the predictor and
outcome variables to determine co-variation among variables and possible
multicollinearity among variables. Short-term abstinence was found to be
strongly correlated with long-term abstinence (r(340) = .874, p < 0.01). Shortterm abstinence was found to be correlated with almost all of the predictor
variables, namely physical health (r(340) = .143, p < 0.01); mental health (r(340)
= .191, p < 0.01); social functioning (r(340) = .114, p < 0.05); and AA involvement
(r(340) = .190, p < 0.01). Similarly, long-term abstinence was correlated with
physical health (r(340) = .160, p < 0.01); mental health (r(340) = .216, p < 0.01);
social functioning (r(340) = .127, p < 0.05); and AA involvement (r(340) = .164, p
< 0.01). Although not correlated with either short-term or long-term abstinence,
gender was found to be mildly correlated with several of the predictor variables,
mental health functioning (r(340) = .153, p < 0.01); social functioning (r(340) =
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.207, p < 0.01); and physical health functioning (r(340) = .130, p < 0.05). Age
was found to be correlated with gender (r(340) = .360, p < 0.01) and will be
controlled for as a covariate in the rest of the analysis.
SF-36 Norms Comparison with Opiate-Dependent Males
The present sample’s scores on the three SF-36 scales (General Health,
Mental Health, and Social Functioning) were compared to general outpatient
psychiatric population norms by age and gender to contextualize the sample.
Table 3 illustrates the mean scores on the three SF-36 scales, by gender and
age group. Among men 45-54 years old, the study sample was significantly
different from men of the same age group in the general population on General
Health (t(38) = 13.899, p < .001), Mental Health (t(38) = 20.436, p < .001), and
Social Functioning (t(38) = 15.773, p < .001). On all scales, the present study
sample scored significantly lower, indicating poorer functioning in all three
domains when compared to the general population sample. Results were similar
among men ages 55-64 years old; the present study sample was significantly
different from men of the same age group in the general population on General
Health (t(128) = 24.691, p < .001), Mental Health (t(128) = 39.130 , p < .001),
and Social Functioning (t(128) = 29.909, p < .001). In the eldest group, results
were similar to the first two age groups. Among men 65 years and older, the
present study sample was significantly different from men of the same age group
on measures of General Health (t(22) = 14.752, p < .001), Mental Health (t(22) =
28.702, p < .001), and Social Functioning (t(22) = 13.469, p < .001).
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SF-36 Norms Comparison with Opiate-Dependent Females
Similar trends were found among the women when compared in the same
way with outpatient psychiatric general population norms. Among women 45-54
years old, the study sample was significantly different from women of the same
age group in the general population on General Health (t(72) = 14.146, p < .001),
Mental Health (t(72) = 20.987 , p < .001), and Social Functioning (t(72) = 12.555,
p < .001). Results were similar among women ages 55-64 years old; the present
study sample was significantly different from women of the same age group in
the general population on General Health (t(73) = 14.949, p < .001), Mental
Health (t(73) = 21.423, p < .001), and Social Functioning (t(73) = 16.588, p <
.001). Among women 65 years and older, there was a very small subgroup (n =
2), and the results of the norms comparison were not conducted due to the
limited statistical power.
Factors Associated with Short-Term Abstinence
A logistic regression analysis was preformed with gender, physical health,
mental health, social support, and AA involvement as predictor variables for
short-term abstinence (Table 4). Age was controlled for as a co-variate due to
the significant difference across age among gender. A total of 340 cases were
analyzed and the full model significantly predicted abstinence (omnibus chisquare = 34.462, df = 6, p < 0.0005). The model accounted for between 9.6%
and 12.9% of the variance in short-term abstinence, with 78.8% of those who
were non-abstinent in the short-term successfully predicted. However, only
45.6% of predictions for the short-term abstinent group were accurate. Table 4
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provides coefficients and the Wald statistic and associated degrees of freedom
and the probability values for each of the predictor variables. This shows that
high mental health functioning and any AA involvement reliably positively
predicted short-term abstinence. The values of the coefficients reveal that each
year increase in age increases the odds of short-term abstinence by a factor of
1.063 (95% CI 1.009 and 1.120) and that high mental health increased the odds
of short-term abstinence by a factor of 2.145 (95% CI 1.247 and 3.692). Any
involvement in AA increased the odds of short-term abstinence by a factor of
2.641 (95% CI 1.652 and 4.222). Post-hoc analysis did not indicate any
significant interaction effects with mental health and gender or AA involvement
and gender.
Factors Associated with Long-Term Abstinence
A similar logistic regression analysis was preformed with gender, physical
health, mental health, social support, and AA involvement as predictor variables
for long-term abstinence (Table 5). Age was controlled for as a co-variate due to
the significant difference across age among gender. A total of 340 cases were
analyzed and the full model significantly predicted long-term abstinence
(omnibus chi-square = 36.667, df = 6, p < 0.0005). The model accounted for
between 10.2% and 14.0% of the variance in long-term abstinence, with 87.0%
of those who were non-abstinent in the long-term successfully predicted.
However, only 34.4% of predictions for the long-term abstinent group were
accurate. Table 5 provides coefficients and the Wald statistic and associated
degrees of freedom and the probability values for each of the predictor variables.
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This shows that high mental health functioning and any AA involvement reliably
positively predicted long-term abstinence. The values of the coefficients reveal
that each year increase in age increases the odds of long-term abstinence by a
factor of 1.073 (95% CI 1.018 and 1.132) and that high mental health increased
the odds of long-term abstinence by a factor of 2.394 (95% CI 1.366 and 4.196).
Any involvement in AA increased the odds of long-term abstinence by a factor of
2.487 (95% CI 1.533 and 4.033). Post-hoc analysis did not indicate any
significant interaction effects with mental health and gender or AA involvement
and gender.
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CHAPTER IV: Discussion
The present study focused on factors related to both short-term and longterm abstinence among opiate-dependent older adults. The participants were
part of an original longitudinal study conducted in the 1980s by Anglin and
colleagues. The current impact of physical health status, mental health status,
social support and AA involvement on the achievement of both short-term and
long-term abstinence and how this population compares on these issues when
compared with their non-using peers.
Comparison to Norms: Research Question 1 and Hypothesis
The first research question in the present study was: how well do predictor
variables distinguish the current sample from a psychiatric outpatient normative
sample, using age- and gender-specific norms? This study question will be
addressed hypothesis by hypothesis.
The first hypothesis, 1a, hypothesized that reported physical health will not
significantly distinguish between participants and psychiatric outpatient
population norms. This hypothesis was not supported. The present analysis
found that both men (in all age groups) and women (ages 45-54 and 55-64) in
the current sample had lower rates of physical health when compared to their
same-age peers.
The second hypothesis, 1b, hypothesized that mental health indicators will
not significantly distinguish between participants and psychiatric outpatient
population norms. This hypothesis was also not supported. It was found that
both men (in all age groups) and women (ages 45-54 and 55-64) in present
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sample had lower rates of mental health when compared to their same-age
peers.
The third hypothesis, 1c, hypothesized that reported social functioning will
not significantly distinguish between participants and psychiatric outpatient
population norms. Similarly, this hypothesis was not supported. It was found
that both men (in all age groups) and women (ages 45-54 and 55-64) in the
current study had lower rates of social support than their same age peers in the
normed group.
The group of women ages 65 and older were not compared to the normed
sample due to the small sample size and limited statistical power. When
compared to psychiatric outpatient general population norms, using the SF-36,
both men (in all age groups) and women (ages 45-54 and 55-64) had poorer
physical and mental health and lower levels of social support than their same age
peers in the general population. This contextualizes the present sample to have
lower physical and mental health levels, and lower social support, illustrating the
need of this population for multi-faceted care and intervention. This is consistent
with previous research (Grella & Lovinger, 2012).
Factors Related to Abstinence: Research Question 2 and Hypothesis
The second research question in the present study was: when age is
controlled for, how well do independent variables (gender, physical health,
mental health, social support, and AA involvement) predict the outcome of shortterm and long-term abstinence? This study question will be addressed
hypothesis by hypothesis. The first hypothesis, 2a, hypothesized that being a
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male will have a significant (at the p > 0.5 level), negative correlation with
abstinence. Subsequently, being a female will have a significant (at the p > 0.5
level), positive correlation with both short-term and long-term abstinence. This
hypothesis was not supported as there was no significant correlation found for
gender with short-term nor long-term abstinence.
The second hypothesis, 2b, hypothesized that physical health status will
have a significant (at the p > 0.5 level), correlation with both short-term and longterm abstinence, in that better physical health will be associated with higher odds
of abstinence outcomes, controlling for other variables. This also was not
supported in the analysis, as there was no significant correlation found for
physical health for either short-term or long-term abstinence.
The third hypothesis, 2c, hypothesized that mental health status will have
a significant (at the p > 0.5 level), correlation with both short-term and long-term
abstinence, in that better mental health status will be associated with higher odds
of abstinence outcomes, controlling for other variables. This hypothesis was
supported. High mental health status was significantly correlated with both shortterm and long-term abstinence. High mental health was associated with
increased odds of short-term abstinence and long-term abstinence. This
suggests that higher mental health has a significant, positive relationship with
both short- and long-term abstinence, in that, better mental health may lead to
abstinence.
The fourth hypothesis, 2d, hypothesized that social functioning will have a
significant (at the p > 0.5 level), positive correlation with both short- and long-

46
term abstinence, controlling for other variables. This also was not supported in
the analysis, as there was no significant correlation found for social support for
either short-term or long-term abstinence.
The last hypothesis, 2e, hypothesized that involvement in Alcoholics
Anonymous will have a significant (at the p > 0.5 level), positive correlation with
both short-term and long-term abstinence, controlling for other variables. This
hypothesis was supported. Any involvement in AA was found to be significantly
correlated with both short- and long-term abstinence. Any involvement in AA
was associated with higher odds of short- and long-term abstinence by a factor of
This suggests that any involvement in AA has a significant, positive relationship
with both short- and long-term abstinence, in that, as AA involvement increases,
abstinence increases.
As higher mental health and any AA involvement is associated with higher
rates of both short- and long-term abstinence, it may be prudent for treatment
providers to tailor interventions accordingly. Treatment providers can address
substance use with interventions such as motivational interviewing or from a
harm-reduction standpoint. In addition, treatment providers can also address
mental health issues, such as depression, anxiety, and trauma, with empiricallysupported treatment methods. Treatment providers may benefit from becoming
more familiar with AA and encouraging patients to increase involvement in AA,
through attending meetings, working the steps, and/or working with a sponsor.
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Limitations
Several limitations of the study should be noted. First, the study sample is
limited to participants who were on methadone maintenance in the 1970s in
Central and Southern California. These findings may have limited
generalizability to samples that use other substances or who live in other
geographic areas.
Another limitation is regarding survivor bias in the present sample, as
approximately 46.8% of participants in the original studies conducted in the
1980s had died. Those participants in the present study are those individuals
who survived and they represent a more robust sample of individuals (as
indicated in Grella & Lovinger, 2011), creating a survivor bias in the data, which
may limit the generalizability of the data to a broader population. Additionally,
there was further attrition from the original sample, with some individuals unable
to be located or opting to not participate, and this may also create a bias in the
sample surveyed. These individuals may have cut off connection with their
former drug-using lifestyle as the entered the next phase of their lives, or they
may have experienced similar or worse outcomes as the present sample.
Limitation with sample size across racial and ethnic groups rendered
analyzing differences by race and ethnicity not possible in the present study.
How race and ethnicity were categorized on the data collection forms was in
conjunction with United States Census standards at the time of the study.
However, as there is an evolving conception of ethnic identity, looking at potential
differences between racial and ethnic groups may be a direction for further
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research. In addition, looking at treatment needs across varying racial and ethnic
groups may also serve to highlight various treatment factors that could help
benefit various communities. For example, Rosen, Goodkind, and Smith (2011)
investigated treatment needs among an older African-American population who
utilized methadone services. Continued work on discerning specific treatment
needs will better help individuals engage in treatment and recovery.
The definition of abstinence is another possible limitation in the present
analysis. Although methadone positive urinalysis results were considered to be
illicit-drug free, individuals could be using methadone in an illicit fashion. The
possibility of error in urinalysis should also be considered as potential limitation in
analyzing urinalysis data. Additionally, the possibility of underreporting of
previous substance use should be considered in the individuals self-report of
past substance use. Although individuals had little reason to provide inaccurate
information, the stigma around substance use or difficulty remembering past
history could possibly influence the accuracy of self-report.
Further, another limitation of the nature of the analysis in the regression
model is that it does not predict causality or the direction of the relationship. The
nature of the relationship or causality between abstinence and mental health or
AA involvement can only be interpreted by association. The present model uses
data collected at one point in time, and the model is testing the associations at
the same time frame. Further, logistic regression is a correlational analysis that
only allows interpretation of the association between certain variables, which
limits the nature of data interpretation.

49
Implications and Conclusions
Despite these limitations, the study findings have important implications
for future research and treatment of older adults who have been diagnosed as
opiate-dependent. There will be a significant increase in the number of older
adults in the next 10 years as the Baby Boomer population ages. This significant
increase will undoubtedly place a strain on treatment providers. As substance
use disorders are seen as chronic conditions that require ongoing (and patientdriven) care, continuing to understand what factors are associated with
abstinence specifically for older individuals will help to effectively tailor and
allocate treatment resources, which is consistent with ongoing research (Rosen,
Morse, & Reynolds, 2010; Wu & Blazer, 2011). Additionally, as alcohol use is
well studied among older adults (Liberto, et al.,1992; Menninger, 2002; Sorocco
& Ferrell, 2006), continued research with opiate users may serve to address
physical and mental health, social support, and 12-step involvement in middle
age and older adults and tailor treatment interventions to best address the needs
of older opiate-dependent adults.
The present analysis suggests that higher mental health status is
positively associated with abstinence. Treatment providers may consider
encouraging continued work on addressing mental health issues, including
assessing for possible dual-diagnosis and treating any co-occurring mental
health issues with evidence-based practices, such as cognitive-behavioral
therapy. Additionally, as AA involvement was significantly associated with
abstinence, treatment providers may also consider encouraging involvement in
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AA or other 12-step groups, working with a sponsor, or reading materials
associated with 12-step groups and working the steps.
In conclusion, individuals with a history of opiate dependence may benefit
from multi-faceted treatment with various treatment interventions, including
managing mental health issues and getting involved in AA. Providing tailored
treatment and educating treatment providers how to screen and treat for these
needs will help best address the growing need of our community.
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APPENDIX A
Accompanying Tables
Table A1
Socio-demographics by Gender
Men
(n=191)

Women
(n=149)

Total
(N=340)

N

%

N

%

N

%

45-54 years

22

11.5

62

41.6

84

24.7

55-64 years

140

73.3

85

57.1

225

66.2

65 + years

29

15.2

2

1.3

31

9.1

White

182

95.3

137

91.9

319

93.8

Non-white

9

4.7

12

8.1

21

6.2

Race

* Significant difference between age across gender (p = 0.05)
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Table A2
Short-term and Long-term Abstinence by Gender
Men
(N=191)
N

Women
(N=149)
%

N

Total
(N=340)
%

N

%

Short-Term (30 Days) Abstinence
Abstinent

85

44.5

62

41.6

147

43.2

Not-Abstinent

106

55.5

87

58.4

193

56.8

Long-Term (at least 1 year) Abstinence
Abstinent

72

37.7

53

35.6

125

36.8

Not-Abstinent

119

62.3

96

64.4

215

63.2
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Table A3
Mean Scores and Standard Deviations on SF-36 Scales by Age and Gender
Age Group
45-54 Years

55-64 Years

65 + Years

Men

Women

Men

Women

Men

Women

(N=39)

(N=73)

(N=129)

(N=74)

(N=23)

(N=2)

General
Health

51.1*

41.3*

50.3*

45.4*

58.7*

60.0

sd=22.9

sd=24.9

sd=23.2

sd=26.1

sd=19.1

sd=35.4

Mental Health

67.4*

56.8*

68.2*

60.1*

78.6*

50.0

sd=20.6

sd=23.1

sd=19.8

sd=24.1

sd=13.1

sd=53.7

68.3*

51.4*

71.0*

60.8*

74.5*

43.8

sd=27.0

sd=34.9

sd=26.9

sd=31.5

sd=26.5

sd=26.5

Social Support
and
Functioning

SF-36 Scales: Scores range from lowest (0) to highest (100) level of functioning
* Significant difference from SF-36 Norm (at the p < 0.01 level)


Comparison to norm not conducted due to small sample size
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Table A4
Logistic Regression Analysis for Short-Term Abstinence
Predictor Variable

B

S.E. Wald

p

Odds Ratio

95% C.I.
Lower

Upper

Age

.061

.027 5.328

.021 1.063

1.009

1.120

Gender

-.290

.256 1.282

.258 .749

.453

1.236

Physical Health

.171

.266 .416

.519 1.187

.705

1.998

Mental Health

.763

.277 7.594

.006 2.145

1.247

3.692

Social Support

.118

.278 .181

.670 1.125

.653

1.939

AA Involvement

.971

.239 16.474 .000 2.641

1.652

4.222

Note. Age is entered as a continuous variable
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Table A5
Logistic Regression Analysis for Long-Term Abstinence
Predictor Variable

B

S.E. Wald

p

Odds Ratio

95% C.I.
Lower

Upper

Age

.071

.027 6.767

.009 1.073

1.018

1.132

Gender

-.383

.265 2.081

.149 .682

.405

1.147

Physical Health

.217

.274 .627

.429 1.242

.726

2.124

Mental Health

.873

.286 9.290

.002 2.394

1.366

4.196

Social Support

.126

.290 .189

.663 1.134

.643

2.003

AA Involvement

.911

.247 13.634 .000 2.487

1.533

4.033

Note. Age is entered as a continuous variable
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APPENDIX B
Breakdown of Original Sample Collected by Anglin & McGlothlin in the 1980s.
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APPENDIX C
Table C1
Variables Used in Analysis, Coding, and Sample Distribution
Variable

Coding

Sample Distribution

45-54

24.7%

55-64

66.2%

65+

9.1%

Continuous

M = 57.3 (sd = 4.7)

White = 0

93.8%

Non-White = 1

6.2%

Female = 0

43.8%

Male= 1

56.2%

Low = 0

49.7%

High = 1

50.5%

Low = 0

51.9%

High = 1

48.1%

SF-36 Social Support and

Low = 0

37.6%

Functioning

High = 1

62.4%

AA Involvement

None = 0

57.1%

Any = 1

42.9%

Non-Abstinent = 0

56.8%

Abstinent = 1

43.2%

Non-Abstinent = 0

63.2%

Abstinent = 1

36.8%

Sociodemographics
Age

Race

Gender

Predictor Variables
SF-36 Physical Health

SF-36 Mental Health

Outcomes
Short-Term Abstinence

Long-Term Abstinence

